Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 11/20 | 0.53 |
| ▸ | MAOA | P21397 | 6/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.50 |
| ▸ | CXCL12 | P48061 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10691949 | 0.89 | MAPT (0.52) | MAOBMAOACXCL12MEN1KMT2A | |
| SCHEMBL10693571 | 0.83 | TTR (0.45) | MEN1KMT2A | |
| SCHEMBL11818074 | 0.73 | MAOB (0.69) | MAOBMAOAABCG2CXCL12CYP1B1 | |
| SCHEMBL11818070 | 0.73 | MAOB (0.69) | MAOBMAOAABCG2CXCL12CYP1B1 | |
| SCHEMBL28505227 | 0.72 | ESR1 (0.53) | MAOBMAOAABCG2CXCL12CYP1B1 | |
| Hydrochloric Acid SCHEMBL11819938 | 0.72 | MAOB (0.68) | MAOBMAOAABCG2CXCL12CYP1B1 | |
| Hydrochloric Acid SCHEMBL11819942 | 0.72 | MAOB (0.68) | MAOBMAOAABCG2CXCL12CYP1B1 | |
| 4',4-Dichlorochalcone SCHEMBL659210 | 0.72 | MAOB (0.86) | MAOBMAOAABCG2CXCL12CYP1B1 | |
| 4',4-Dichlorochalcone SCHEMBL659211 | 0.72 | MAOB (0.86) | MAOBMAOAABCG2CXCL12CYP1B1 | |
| SCHEMBL28017674 | 0.71 | IP6K1 (0.56) | MAOBMAOAABCG2CXCL12CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4778792-A | Use of 7-acyl benzoxazinones and their derivatives in treating atheromatous disorders | LABORATORIES NEGMA (FR) | 1988-10-18 | — | — | US | disclosed |